BRD2 Antikörper (AA 167-256)
Kurzübersicht für BRD2 Antikörper (AA 167-256) (ABIN562664)
Target
Alle BRD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 167-256
-
Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant BRD2.
-
Sequenz
- QTLEKIFLQK VASMPQEEQE LVVTIPKNSH KKGAKLAALQ GSVTSAHQVP AVSSVSHTAL YTPPPEIPTT VLNIPHPSVI SSPLLKSLHS
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- BRD2 (NP_005095, 167 a.a. ~ 256 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma." in: Cancer cell, Vol. 24, Issue 5, pp. 603-16, (2013) (PubMed).
-
: "Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma." in: Cancer cell, Vol. 24, Issue 5, pp. 603-16, (2013) (PubMed).
-
- BRD2 (Bromodomain Containing 2 (BRD2))
-
Andere Bezeichnung
- BRD2
-
Hintergrund
-
Full Gene Name: bromodomain containing 2
Synonyms: D6S113E,DKFZp686N0336,FLJ31942,FSH,FSRG1,KIAA9001,NAT,RING3,RNF3 -
Gen-ID
- 6046
-
NCBI Accession
- NM_005104
-
Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-